X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse GSK Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs TEVA PHARMA (Israel) - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-18
TEVA PHARMA
Dec-13
GSK PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,7602,872-   
Low Rs2,0402,495-   
Sales per share (Unadj.) Rs339.01,648.1-  
Earnings per share (Unadj.) Rs41.4103.0-  
Cash flow per share (Unadj.) Rs45.9236.2-  
Dividends per share (Unadj.) Rs35.0090.13-  
Dividend yield (eoy) %1.53.4 43.4%  
Book value per share (Unadj.) Rs242.91,830.7-  
Shares outstanding (eoy) m84.70848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.11.6 434.8%   
Avg P/E ratio x57.926.1 222.3%  
P/CF ratio (eoy) x52.311.4 460.2%  
Price / Book Value ratio x9.91.5 674.2%  
Dividend payout %84.587.5 96.5%   
Avg Mkt Cap Rs m203,2802,275,354 8.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m5,2340-   
Avg. sales/employee Rs ThNM31,095.9-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,942.5-  
INCOME DATA
Net Sales Rs m28,7151,397,603 2.1%  
Other income Rs m5450-   
Total revenues Rs m29,2601,397,603 2.1%   
Gross profit Rs m5,059382,734 1.3%  
Depreciation Rs m380112,970 0.3%   
Interest Rs m227,451 0.0%   
Profit before tax Rs m5,222242,314 2.2%   
Minority Interest Rs m01,101 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m178-159,066 -0.1%   
Tax Rs m1,892-2,958 -64.0%   
Profit after tax Rs m3,50887,307 4.0%  
Gross profit margin %17.627.4 64.3%  
Effective tax rate %36.2-1.2 -2,967.6%   
Net profit margin %12.26.2 195.6%  
BALANCE SHEET DATA
Current assets Rs m21,815943,936 2.3%   
Current liabilities Rs m15,999823,192 1.9%   
Net working cap to sales %20.38.6 234.4%  
Current ratio x1.41.1 118.9%  
Inventory Days Days6491 70.0%  
Debtors Days Days1996 19.5%  
Net fixed assets Rs m12,475456,488 2.7%   
Share capital Rs m8473,440 24.6%   
"Free" reserves Rs m19,7260-   
Net worth Rs m20,5731,552,472 1.3%   
Long term debt Rs m6714,626 0.0%   
Total assets Rs m39,4753,193,971 1.2%  
Interest coverage x2,612.09.8 26,579.6%   
Debt to equity ratio x00.5 0.1%  
Sales to assets ratio x0.70.4 166.2%   
Return on assets %8.93.6 247.5%  
Return on equity %17.15.6 303.2%  
Return on capital %26.24.9 532.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,8650-   
CASH FLOW
From Operations Rs m4,728222,706 2.1%  
From Investments Rs m-1,042-78,914 1.3%  
From Financial Activity Rs m-3,066-267,150 1.1%  
Net Cashflow Rs m620-123,358 -0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.8 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare GSK PHARMA With: ABBOTT INDIA  MERCK LTD  BIOCON LTD  IPCA LABS  PANACEA BIOTECH  



Today's Market

Sensex Ends Volatile Day Flat; Pharma Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day flat.

Related Views On News

GSK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 6.4% YoY). Sales on the other hand came in at Rs 7 bn (down 4.5% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Jul 19, 2018 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS